Brief Report: Role of Sociobehavioral Factors in Subprotective TFV-DP Levels Among YMSM Enrolled in 2 PrEP Trials.
Adenine
/ analogs & derivatives
Adolescent
Anti-HIV Agents
/ therapeutic use
HIV Infections
/ prevention & control
Health Surveys
Homosexuality, Male
Humans
Male
Medication Adherence
/ psychology
Organophosphates
/ therapeutic use
Patient Acceptance of Health Care
/ psychology
Pre-Exposure Prophylaxis
Risk-Taking
Young Adult
Journal
Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005
Informations de publication
Date de publication:
01 02 2019
01 02 2019
Historique:
entrez:
15
1
2019
pubmed:
15
1
2019
medline:
31
10
2019
Statut:
ppublish
Résumé
Young men who have sex with men (YMSM) experience disparities in HIV acquisition more than any other group. Daily oral pre-exposure prophylaxis (PrEP) with tenofovir/emtricitabine has been shown to effectively prevent HIV transmission in YMSM; however, recent studies suggest that young Black men who have sex with men experience subprotective levels of tenofovir diphosphate more frequently than other groups. Combined data from Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 110/113, 2 open-label PrEP studies that provided PrEP and evidence-based behavioral interventions to YMSM aged 15-22 years. Bivariate and logistic regression analyses were used to examine sociodemographic and behavioral factors associated with protective tenofovir diphosphate levels (defined as ≥700 fmol/punch) in ATN 110/113 data. In bivariate analysis, self-identified Black participants, residential displacement due to sexual orientation, low perceived risk, and stigma with the medication were associated with subprotective levels. Hispanic ethnicity was associated with protective levels. In the final models, Black males were less likely to have subprotective levels than non-Black males at 4, 8, and 12 weeks. Self-reported displacement due to sexual orientation was associated with subprotective levels, whereas older age was as associated with protective levels. These findings highlight how future behavioral research and biomedical prevention efforts in YMSM will need to address PrEP disparities that may occur in young Black men who have sex with men, perception of risk, and lack of key supportive housing during this period that may be critical factors that contribute to HIV acquisition.
Sections du résumé
BACKGROUND
Young men who have sex with men (YMSM) experience disparities in HIV acquisition more than any other group. Daily oral pre-exposure prophylaxis (PrEP) with tenofovir/emtricitabine has been shown to effectively prevent HIV transmission in YMSM; however, recent studies suggest that young Black men who have sex with men experience subprotective levels of tenofovir diphosphate more frequently than other groups.
SETTING
Combined data from Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 110/113, 2 open-label PrEP studies that provided PrEP and evidence-based behavioral interventions to YMSM aged 15-22 years.
METHODS
Bivariate and logistic regression analyses were used to examine sociodemographic and behavioral factors associated with protective tenofovir diphosphate levels (defined as ≥700 fmol/punch) in ATN 110/113 data.
RESULTS
In bivariate analysis, self-identified Black participants, residential displacement due to sexual orientation, low perceived risk, and stigma with the medication were associated with subprotective levels. Hispanic ethnicity was associated with protective levels. In the final models, Black males were less likely to have subprotective levels than non-Black males at 4, 8, and 12 weeks. Self-reported displacement due to sexual orientation was associated with subprotective levels, whereas older age was as associated with protective levels.
CONCLUSIONS
These findings highlight how future behavioral research and biomedical prevention efforts in YMSM will need to address PrEP disparities that may occur in young Black men who have sex with men, perception of risk, and lack of key supportive housing during this period that may be critical factors that contribute to HIV acquisition.
Identifiants
pubmed: 30640203
doi: 10.1097/QAI.0000000000001901
pii: 00126334-201902010-00005
pmc: PMC6486465
mid: NIHMS1510184
doi:
Substances chimiques
Anti-HIV Agents
0
Organophosphates
0
tenofovir diphosphate
0
Adenine
JAC85A2161
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
160-165Subventions
Organisme : NICHD NIH HHS
ID : U01 HD040474
Pays : United States
Organisme : NICHD NIH HHS
ID : U01 HD040533
Pays : United States
Références
PLoS One. 2018 Jul 25;13(7):e0200560
pubmed: 30044845
AIDS Behav. 2017 May;21(5):1236-1246
pubmed: 28108878
Soc Sci Med. 2000 Jun;50(11):1599-605
pubmed: 10795966
J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):528-37
pubmed: 25230290
Pediatr Clin North Am. 2016 Dec;63(6):1091-1106
pubmed: 27865335
J Adolesc Health. 2012 Oct;51(4):386-92
pubmed: 22999840
JAMA Pediatr. 2017 Nov 1;171(11):1041-1042
pubmed: 28873123
PLoS One. 2017 Feb 21;12(2):e0172354
pubmed: 28222118
Lancet Infect Dis. 2014 Sep;14(9):820-9
pubmed: 25065857
Clin Infect Dis. 2018 Mar 5;66(6):936-944
pubmed: 29069298
JAMA Intern Med. 2016 Jan;176(1):75-84
pubmed: 26571482
AIDS Behav. 2017 May;21(5):1376-1382
pubmed: 28238119
JAMA Pediatr. 2017 Nov 1;171(11):1063-1071
pubmed: 28873128
J Adolesc Health. 2016 Dec;59(6):725-728
pubmed: 27720357
Am J Community Psychol. 1993 Aug;21(4):421-48
pubmed: 8192119
AIDS Res Hum Retroviruses. 2013 Feb;29(2):384-90
pubmed: 22935078
N Engl J Med. 2010 Dec 30;363(27):2587-99
pubmed: 21091279
PLoS One. 2013 Jul 26;8(7):e70413
pubmed: 23922989
Addict Behav. 2001 May-Jun;26(3):415-23
pubmed: 11436933
AIDS Behav. 2007 Nov;11(6 Suppl):56-69
pubmed: 17265143
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):21-29
pubmed: 27632233